PharmaCyte Biotech, Inc.
- SEC CIK
- 0001157075
No open-market purchases or sales filed in the past year.
Current role at each company
- FEMY Femasys Inc10% Owneras of Mar 18, 2026
- QCLS Q/C Technologies, Inc.10% Owneras of Nov 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists PharmaCyte Biotech, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QCLS Q/C Technologies, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 (view filing) | Sep 4-Nov 14 | 75 daysLate | PharmaCyte Biotech, Inc.10% Owner | PPurchaseCommon stock, par value $0.001 per share | +1.78M | – | – | –889.9K after | Derivative2 lots |